Indications and outcome of salvage surgery for oesophageal cancer

European Journal of Cardio-thoracic Surgery

Volumn 33, Issue 6, 2008, Pages 1117-1123

  D'Journo, Xavier Benoit ^a   Michelet, Pierre ^a   Dahan, Laetitia ^b   Doddoli, Christophe ^a,c   Seitz, Jean François ^b   Giudicelli, Roger ^a   Fuentes, Pierre A ^a   Thomas, Pascal A ^a,c  

^a HÔPITAL SAINTE MARGUERITE   (France)

^b TIMONE HOSPITAL   (France)

^c AIX MARSEILLE UNIVERSITY   (France)

Author keywords

Chemotherapy; Oesophageal neoplasms; Oesophagectomy; Radiotherapy

Indexed keywords

CISPLATIN; FLUOROURACIL;

ADULT; AGED; ANASTOMOSIS LEAKAGE; ARTICLE; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RELAPSE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; DISEASE FREE SURVIVAL; ERYTHROCYTE COUNT; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGITIS; ESOPHAGUS BIOPSY; ESOPHAGUS PERFORATION; ESOPHAGUS RESECTION; ESOPHAGUS STENOSIS; FEMALE; HEART FAILURE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LENGTH OF STAY; LYMPHADENECTOMY; MALE; PRIORITY JOURNAL; QUALITY OF LIFE; RADIATION DOSE; RISK BENEFIT ANALYSIS; SALVAGE THERAPY; TREATMENT INDICATION; TREATMENT OUTCOME;

AGED; COMBINED MODALITY THERAPY; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PATIENT SELECTION; QUALITY OF LIFE; RECURRENCE; RETROSPECTIVE STUDIES; SALVAGE THERAPY; SURVIVAL ANALYSIS; TREATMENT OUTCOME; VITAL CAPACITY;

EID: 43049159690     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcts.2008.01.056     Document Type: Article

References (25)

1. Gebski V., Burmeister B., Smithers B.M., Foo K., Zalcberg J., Simes J., and Australasian Gastro-Intestinal Trials Group. Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis. Lancet Oncol 8 (2007) 226-234
2. Stahl M., Stuschke M., Lehmann N., Meyer H.J., Walz M.K., Seeber S., Klump B., Budach W., Teichmann R., Schmitt M., Schmitt G., Franke C., and Wilke H. Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus. J Clin Oncol 23 (2005) 2310-2317
3. Bedenne L., Michel P., Bouche O., Milan C., Mariette C., Conroy T., Pezet D., Roullet B., Seitz J.F., Herr J.P., Paillot B., Arveux P., Bonnetain F., and Binquet C. Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102. J Clin Oncol 25 (2007) 1160-1168
4. Fiorica F., Di Bona D., Schepis F., Licata A., Shahied L., Venturi A., Falchi A.M., Craxi A., and Camma C. Preoperative chemoradiotherapy for oesophageal cancer: a systematic review and meta-analysis. Gut 53 (2004) 925-930
5. Bonnetain F., Bouche O., Michel P., Mariette C., Conroy T., Pezet D., Roullet B., Seitz J.F., Paillot B., Arveux P., Milan C., and Bedenne L. A comparative longitudinal quality of life study using the Spitzer quality of life index in a randomized multicenter phase III trial (FFCD 9102): chemoradiation followed by surgery compared with chemoradiation alone in locally advanced squamous resectable thoracic esophageal cancer. Ann Oncol 17 (2006) 827-834
6. Herskovic A., Martz K., al-Sarraf M., Leichman L., Brindle J., Vaitkevicius V., Cooper J., Byhardt R., Davis L., and Emami B. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med 326 (1992) 1593-1598
7. Cooper J.S., Guo M.D., Herskovic A., Macdonald J.S., Martenson Jr. J.A., Al-Sarraf M., Byhardt R., Russell A.H., Beitler J.J., Spencer S., Asbell S.O., Graham M.V., and Leichman L.L. Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group. JAMA 281 (1999) 1623-1627
8. Meunier B., Raoul J., Le Prise E., Lakehal M., and Launois B. Salvage esophagectomy after unsuccessful curative chemoradiotherapy for squamous cell cancer of the esophagus. Dig Surg 15 (1998) 224-226
9. Swisher S.G., Wynn P., Putnam J.B., Mosheim M.B., Correa A.M., Komaki R.R., Ajani J.A., Smythe W.R., Vaporciyan A.A., Roth J.A., and Walsh G.L. Salvage esophagectomy for recurrent tumors after definitive chemotherapy and radiotherapy. J Thorac Cardiovasc Surg 123 (2002) 175-183
10. Nakamura T., Hayashi K., Ota M., Eguchi R., Ide H., Takasaki K., and Mitsuhashi N. Salvage esophagectomy after definitive chemotherapy and radiotherapy for advanced esophageal cancer. Am J Surg 188 (2004) 261-266
11. Tomimaru Y., Yano M., Takachi K., Miyashiro I., Ishihara R., Nishiyama K., Sasaki Y., Ishikawa O., Doki Y., and Imaoka S. Factors affecting the prognosis of patients with esophageal cancer undergoing salvage surgery after definitive chemoradiotherapy. J Surg Oncol 93 (2006) 422-428
12. Oki E., Morita M., Kakeji Y., Ikebe M., Sadanaga N., Egasira A., Nishida K., Koga T., Ohata M., Honboh T., Yamamoto M., Baba H., and Maehara Y. Salvage esophagectomy after definitive chemoradiotherapy for esophageal cancer. Dis Esophagus 20 (2007) 301-304
13. In: Sobin L.H., and Wittekid C. (Eds). TNM Classification of Malignant Tumors. International Union Against Cancer. 5th ed. (1997), Wiley, New York, NY
14. Michelet P., Roch A., D'Journo X.B., Blayac D., Barrau K., Papazian L., Thomas P., and Auffray J.P. Effect of thoracic epidural analgesia on gastric blood flow after oesophagectomy. Acta Anaesthesiol Scand 51 (2007) 587-594
15. Michelet P., D'Journo X.B., Roch A., Papazian L., Ragni J., Thomas P., and Auffray J.P. Perioperative risk factors for anastomotic leakage after esophagectomy: influence of thoracic epidural analgesia. Chest 128 (2005) 3461-3466
16. Moureau-Zabotto L., Touboul E., Lerouge D., Deniaud-Alexandre E., Grahek D., Foulquier J.N., Petegnief Y., Gres B., El Balaa H., Kerrou K., Montravers F., Keraudy K., Tiret E., Gendre J.P., Grange J.D., Houry S., and Talbot J.N. Impact of CT and 18F-deoxyglucose positron emission tomography image fusion for conformal radiotherapy in esophageal carcinoma. Int J Radiat Oncol Biol Phys 63 (2005) 340-345
17. Abou-Jawde R.M., Mekhail T., Adelstein D.J., Rybicki L.A., Mazzone P.J., Caroll M.A., and Rice T.W. Impact of induction concurrent chemoradiotherapy on pulmonary function and postoperative acute respiratory complications in esophageal cancer. Chest 128 (2005) 250-255
18. Wang S.L., Liao Z., Vaporciyan A.A., Tucker S.L., Liu H., Wei X., Swisher S., Ajani J.A., Cox J.D., and Komaki R. Investigation of clinical and dosimetric factors associated with postoperative pulmonary complications in esophageal cancer patients treated with concurrent chemoradiotherapy followed by surgery. Int J Radiat Oncol Biol Phys 64 (2006) 692-699
19. Plukker J.T., and van Westreenen H.L. Staging in oesophageal cancer. Best Pract Res Clin Gastroenterol 20 (2006) 877-891
20. Port J.L., Lee P.C., Korst R.J., Liss Y., Meherally D., Christos P., Mazumdar M., and Altorki N.K. Positron emission tomographic scanning predicts survival after induction chemotherapy for esophageal carcinoma. Ann Thorac Surg 84 (2007) 393-400
21. Swisher S.G., Maish M., Erasmus J.J., Correa A.M., Ajani J.A., Bresalier R., Komaki R., Macapinlac H., Munden R.F., Putnam J.B., Rice D., Smythe W.R., Vaporciyan A.A., Walsh G.L., Wu T.T., and Roth J.A. Utility of PET, CT, and EUS to identify pathologic responders in esophageal cancer. Ann Thorac Surg 78 (2004) 1152-1160
22. Dexter S.P., Sue-Ling H., McMahon M.J., Quirke P., Mapstone N., and Martin I.G. Circumferential resection margin involvement: an independent predictor of survival following surgery for oesophageal cancer. Gut 48 (2001) 667-670
23. Laterza E., de Manzoni G., Guglielmi A., Rodella L., Tedesco P., and Cordiano C. Endoscopic ultrasonography in the staging of esophageal carcinoma after preoperative radiotherapy and chemotherapy. Ann Thorac Surg 67 (1999) 1466-1469
24. Piessen G., Briez N., Triboulet J.P., and Mariette C. Patients with locally advanced esophageal carcinoma nonresponder to radiochemotherapy: who will benefit from surgery?. Ann Surg Oncol 14 (2007) 2036-2044
25. Mariette C., Piessen G., and Triboulet J.P. Therapeutic strategies in oesophageal carcinoma: role of surgery and other modalities. Lancet Oncol 8 (2007) 545-553